AirSculpt Technologies (AIRS) Q1 2024: Same-Store Revenue Drops 10% as De Novo Centers Offset Consumer Weakness

May 10, 2024 | By EarningsIQ Research

Persistent softness in core same-store growth and elevated marketing costs weighed on AirSculpt’s Q1, with de novo centers the lone bright spot. Management’s optimism rests on new center outperformance and a strategic marketing pivot, but guidance implies a sharp second-half rebound that will require flawless execution. Investors face a visibility gap as macro headwinds keep core demand muted and CAC remains high.

Summary

• De Novo Outperformance: New center openings outpaced expectations, partially offsetting core demand weakness.
• Marketing Cost Surge: Customer acquisition costs jumped as paid search and awareness spend rose amid tougher competition.
• Second-Half Rebound Reliance: Full-year targets hinge on improving conversion from organic leads and a seasonal recovery.

Business Overview

AirSculpt Technologies operates a network of body contouring centers offering minimally invasive fat removal procedures, primarily under the AirSculpt brand. The company generates revenue from patient-paid procedures, with a growing footprint of de novo (newly opened) centers supplementing its established base. Major segments include same-store centers and new de novo locations, with marketing and patient financing as key business levers.

Performance Analysis

AirSculpt delivered low single-digit revenue growth, driven entirely by new de novo center openings, while same-store revenue contracted nearly 10% year-over-year. Management attributed the softness to macroeconomic pressures impacting price-sensitive customers, a trend consistent with the broader aesthetics and high-end consumer retail sector. Despite a typical seasonal uptick, the magnitude of the rebound lagged historical norms, keeping overall volumes below expectations.

Adjusted EBITDA fell sharply, reflecting both the revenue shortfall and a significant ramp in selling and marketing expenses. Customer acquisition cost (CAC) surged 27% to $2,990 per case, as competitive intensity in paid search and a push for brand awareness pressured margins. Cost of service as a percent of revenue improved, but these gains were more than offset by higher SG&A investment. Cash flow conversion slipped, and management reinvested cost savings into marketing rather than margin preservation.

• De Novo Center Contribution: Openings in 2023 and early 2024 drove all top-line growth, validating site selection and ramp strategies.
• Same-Store Drag: Core centers underperformed, with management guiding for continued weakness through Q2 and only modest improvement in the back half.
• Marketing Spend Escalation: Increased paid search and a shift to organic and earned media raised CAC and squeezed near-term profitability.

All centers remained profitable, but the London location lagged ramp expectations, underscoring the challenges of international expansion. Financing usage remained stable at 50%, and the company’s balance sheet retained flexibility with $11 million in cash and undrawn debt capacity.

Executive Commentary

Strategic Positioning

1. De Novo Expansion as Growth Engine

AirSculpt’s de novo strategy—opening new centers in underpenetrated markets—is the primary driver of revenue growth, with the 2023 class outperforming internal benchmarks. Six new centers are slated for 2024, with four scheduled in Q3, reflecting confidence in site analytics and a proven quick-ramp playbook.

2. Marketing Model Evolution

Management is pivoting from paid search dependence to a diversified media approach, emphasizing organic search, connected TV, and smaller, more frequent celebrity partnerships. This “string of pearls” earned media strategy aims to generate sustainable lead flow and lower CAC over time, though current spend remains elevated as the transition unfolds.

3. Selective Discounting and Brand Protection

Despite soft demand, leadership is avoiding broad-based price cuts, instead relying on targeted promotions and “buy more, save more” offers to protect premium brand positioning. This approach seeks to balance volume support with long-term brand equity, though it may limit near-term case growth versus more aggressive discounting peers.

4. Cost Management and Reinvestment

Cost savings initiatives delivered a $5 million annualized run rate, but rather than flow to the bottom line, these savings are being reinvested in marketing to drive future growth. Management sees additional efficiency opportunities in the second half, with a clear bias toward fueling top-line recovery over margin expansion in the near term.

Key Considerations

This quarter spotlights a business at a strategic crossroads, balancing near-term demand softness with investments designed to reignite growth. Execution on both new center ramp and marketing efficiency will be critical to delivering on full-year guidance.

Key Considerations:

• Lead Quality Over Quantity: Shift toward organic and earned media is generating higher-intent leads, but conversion timing creates a lag between spend and volume recovery.
• Seasonality Uncertainty: The typical Q2 seasonal lift has been delayed, raising questions about the duration and magnitude of pent-up demand.
• International Ramp Risk: London center’s slow ramp highlights the complexity of overseas market entry and the need for tailored playbooks.
• Brand Equity vs. Volume Levers: Reluctance to broadly discount may support pricing but could cede share to more aggressive competitors if demand remains weak.

Risks

Persistent macro headwinds, especially among price-sensitive consumers, could extend same-store declines and pressure volumes into the back half. Elevated CAC and delayed lead conversion add uncertainty to the timing of revenue recovery, while international expansion brings execution risk. Failure to deliver on new center ramp or marketing efficiency improvements would force a reset of full-year guidance and potentially erode investor confidence.

Forward Outlook

For Q2, AirSculpt guided to:

• Flat or slightly down year-over-year revenue, reflecting continued softness in core demand and a delayed seasonal uptick.
• Elevated customer acquisition costs as marketing investments remain high.

For full-year 2024, management maintained guidance:

• Revenue of approximately $220 million
• Adjusted EBITDA of approximately $50 million

Management highlighted several factors that underpin their cautious optimism:

• Conversion of higher-quality organic leads as marketing mix shifts take hold
• Outperformance of recent de novo centers and strong pipeline for new openings in the second half

Takeaways

AirSculpt remains in a transition phase, with new centers and a marketing overhaul offsetting entrenched demand softness in the core business.

• Core Headwinds Persist: Same-store contraction and delayed seasonality signal ongoing macro and competitive pressure on the base business.
• Execution Levers in Focus: Success of de novo ramp and lead conversion from organic channels will determine second-half recovery and guidance credibility.
• Watch for CAC Inflection: Sustained high marketing costs are a key risk; investors should monitor for evidence of efficiency gains and volume rebound as new strategies mature.

Conclusion

AirSculpt’s Q1 results highlight a business in reset mode, with growth now reliant on new centers and a marketing transformation. Guidance implies a sharp rebound in the second half—investors should closely track conversion rates and cost discipline as the year unfolds.

Industry Read-Through

AirSculpt’s experience mirrors broader challenges in elective aesthetics and high-end consumer services, where macro pressure is weighing on discretionary spend and customer acquisition costs are rising across the board. The pivot to organic and influencer-driven marketing is a notable trend, with implications for digital ad platforms and agencies serving the sector. International expansion remains a tough nut to crack, as evidenced by the slow ramp in London—a cautionary tale for peers eyeing overseas growth. Investors should expect continued volatility in the sector until clear signs of demand stabilization and marketing ROI emerge.

AIRS Healthcare Aesthetics Marketing De Novo Organic Search Consumer